Retatrutide

Retatrutide is a GLP-1/GIP/glucagon triple receptor agonist and the flagship compound in the Riptide catalog. Available as individual vials for experienced researchers or as Protocol A (2mg/week) and Protocol B (5mg/week) bundles with vials pre-matched to your cycle length.